Vaso Corporation

Equities

VASO

US92233F1021

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 03:33:17 2024-05-15 pm EDT 5-day change 1st Jan Change
0.24 USD -11.11% Intraday chart for Vaso Corporation -7.16% -21.31%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Vaso Corporation entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction. CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Vaso Corporation Appoints Leon Dembo as Independent Director CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Vaso Corporation Receives Confirmation That the Small Business Administration Approves the Company's PPP Note Forgiveness Application CI
Vaso Corporation Announces Earnings Results for the First Quarter Ended March 31, 2021 CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Vaso Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Vaso : Earnings Flash (VASO) VASO CORPORATION Posts Q3 Revenue $17.5M MT
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Vaso Corporation Names Jane Moen as Class II Director CI
Vaso Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Chart Vaso Corporation
More charts
Vaso Corporation is principally engaged in operating the healthcare equipment and information technology industries. The Company's segments include IT, Professional sales service, and Equipment. The IT segment operates through a wholly owned subsidiary, VasoTechnology, Inc., which primarily focuses on healthcare information technology (IT) and managed network technology services. Its Professional sales service segment operates through a wholly owned subsidiary, Vaso Diagnostics, Inc. doing business as VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for GE HealthCare (GEHC) into the health provider middle market. Its Equipment segment primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through the Company's subsidiary, VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.
More about the company
  1. Stock Market
  2. Equities
  3. VASO Stock
  4. News Vaso Corporation
  5. Vaso : Earnings Flash (VASO) VASO CORPORATION Posts Q3 Revenue $17.5M
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW